EXEL EXELIXIS INC

2026Q1 · CUSIP 30161Q104 · Sector: Healthcare & Biotech

Cooling · Breadth rolling over

Holders

692

Δ holders QoQ

+12

Breadth percentile

Top 25%

Whale holders

246

Δ whales

Inst. holding value

$11.0B

New positions

104

Closed positions

Price momentum (1Q)

+13.1%

Put / Call

8/9

Breadth history (34 quarters)

Past Lit Events & Aftermath 16 lit events

Period	Percentile	Next-1Q return	Next-2Q return
2025Q4	Top 8%	+13.1%	—
2025Q2	Top 2%	+10.3%	+17.8%
2025Q1	Top 4%	-16.0%	-5.1%
2024Q4	Top 6%	+30.7%	+9.7%
2024Q3	Top 7%	+6.7%	+24.2%
2023Q4	Top 18%	+2.1%	+29.8%
2023Q3	Top 9%	-1.7%	+0.4%
2023Q2	Top 15%	+0.2%	-3.4%
2022Q3	Top 3%	+3.8%	+17.4%
2022Q2	Top 14%	-14.4%	-8.9%
2022Q1	Top 4%	-6.7%	-18.8%
2020Q2	Top 8%	-11.2%	+0.7%
2020Q1	Top 12%	-11.6%	-21.5%
2019Q1	Top 7%	+12.4%	-13.8%
2018Q4	Top 8%	-8.1%	+6.1%
2018Q3	Top 17%	+18.4%	+14.5%

Show all 16 events

Options Sentiment

Put holders

QoQ: -3

Call holders

QoQ: -2

See methodology →

Fundamentals

PE (TTM)

18.4

EPS (TTM)

$3.02

EPS YoY

+37.9%

Revenue (TTM)

$2.4B

Revenue YoY

+3.3%

Net margin

35.1%

ROE

43.0%

Debt ratio

25.4%

FCF (TTM)

$918M

Dividend (TTM)

No dividend

Quarterly Revenue & EPS (4Y)

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-04-03 · SEC filings (XBRL)

Get the next update

2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.